6 Followers on Owler

Vivocapital

Read more
Frank Kung's photo - Managing Partner of Vivocapital

Managing Partner

Frank Kung

CEO Approval Rating

71/100

Founded:

1996

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

Vivocapital Acquisitions

No recent acquisitions found related to Vivocapital

Vivocapital Funding History

Since Vivocapital was founded in 1996, it has participated in 3 rounds of funding. In total Vivocapital has raised $2.7B. Vivocapital's last funding round was on Oct 2019 for a total of $1.4B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Investment Fund
Oct 2019
$1.4B
-
Investment Fund
Aug 2018
$1.3B
-
Investment Fund
May 2016
--
-

Since Vivocapital was founded in 1996, it has participated in 3 rounds of funding. In total Vivocapital has raised $2.7B. Vivocapital's last funding round was on Oct 2019 for a total of $1.4B

Vivocapital Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

RayzeBio is a California-based biopharmaceutical company that develops and commercializes radiopharmaceutical drugs for the treatment of cancer.
$108M
Jun 07, 2021
Series C
-
$50M
May 26, 2021
Growth
-
Esco is a Singapore-based manufacturer and distributor of biological safety cabinets, CO2 incubators, blowers, and related products for healthcare organizations.
$200M
May 25, 2021
Series A
-
Aerpio is an Ohio-based biopharmaceutical company that develops and commercializes Tie2-based protein therapeutics for the treatment of ocular diseases.
$155M
May 16, 2021
PIPE
-
Aerobiotix is an Ohio-based designer, developer and manufacturer of disinfection filtration systems and related products for healthcare, commercial and residential sectors.
$25M
May 05, 2021
Growth
-

Vivocapital News

May 29, 2021Medical Buyer

Scientia secures $50m funding to advance neurovascular products

Utah-based interventional medical devices company Scientia Vascular has received $50m of growth equit... See more »
May 28, 2021VC News Daily

Scientia Vascular Raises $50M Growth Investment

SALT LAKE CITY, UT, Scientia Vascular, a medical device company, has raised $50M of growth equity fin... See more »
May 27, 2021ChinaBio Today

Esco Lifesciences Raises $200 Million to Expand Life Science Tools Portfolio

Esco Lifesciences of Singapore, an Asia-based life sciences tools company, closed an over-subscribed ... See more »
May 27, 2021FinSMEs

Esco Lifesciences Closes US$200M Series A Funding

Esco Lifesciences, a Singapore-based provider of life sciences tools and services, closed a US$200m S... See more »
May 26, 2021FierceBiotech

Esco raises $200M to set up Boston cell and gene therapy hub

Esco raises $200M to set up Boston cell and gene therapy hub ntaylor Wed, 05/26/2021 - 11:48... See more »
May 23, 2021FinSMEs

Sera Prognostics Completes $100M Series E Financing

Sera Prognostics, Inc., a Salt Lake City,...... See more »
May 8, 2021FinTech InShorts

Raises $25M in Growth Equity Financing -

Aerobiotix: Raises $25M in Growth Equity Financing... See more »

Vivocapital Press Releases

January 7, 2021PR Newswire Asia

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies

CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biote... See more »
January 6, 2021PR Newswire

Sern Bioscience Announces Investment by Vivo Capital

BEND, Ore., Jan. 6, 2021 /PRNewswire/ -- Serán Bioscience today announced that healthcare investment... See more »
December 22, 2020EIN Presswire

Provivi raises $45.5M to expand global launch

Successfully introducing insect pheromones to control damaging pests, the increased funding will stre... See more »
March 4, 2019Newswire

MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital

Investment will accelerate domestic and international sales through expansion of workforce and compan... See more »
January 10, 2017Blackbird

BRIEF-Vivo Capital LLC reports 8.52 pct passive stake in Strongbridge Biopharma- SEC filing

Jan 10 Strongbridge Biopharma Plc * Vivo Capital VIII LLC reports 8.52 percent passive stake in Stron... See more »

Social Media

Vivocapital Headquarters

575 High St Ste 201 Suite 201

Palo Alto, California94301

1-650-688-0818

Driving Directions »

Trending Companies

Vivocapital Summary

ABOUT

Overview

Vivo Capital is a venture capital firm that focuses on investments in healthcare and pharmaceutical companies. Vivocapital was founded in 1996. Vivocapital's headquarters is located in Palo Alto, California, USA 94301. It has raised 2.7B in 3 rounds. ...

CEO

Vivocapital's Managing Partner, Frank Kung, currently has an approval rating of 71%. Vivocapital's primary competitors are

Frequently Asked Questions about Vivocapital

  1. When was Vivocapital founded?

    Vivocapital was founded in 1996
  2. Who is Vivocapital's CEO?

    Vivocapital's CEO is Frank Kung
  3. How much revenue does Vivocapital generate?

    Vivocapital generates $ < 1M in revenue
  4. How much funding does Vivocapital have?

    Vivocapital has historically raised $2.7B in funding
  1. Where is Vivocapital's headquarters?

    Vivocapital's headquarters is in Palo Alto California, USA
  2. How many employees does Vivocapital have?

    Vivocapital has 0 employees
  3. Who has Vivocapital invested in?

    Vivocapital's has invested in companies such as RayzeBio, Scientia Vascular, Esco Micro Pte Ltd